Zobrazeno 1 - 10
of 151
pro vyhledávání: '"M Brewis"'
Autor:
D. M. Brewis, I. Mathieson
Publikováno v:
First International Congress on Adhesion Science and Technology---invited papers ISBN: 9780429087486
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::102729ea66c1cfd7529bbf95c32b5e12
https://doi.org/10.1201/9780429087486-18
https://doi.org/10.1201/9780429087486-18
Publikováno v:
‘Mission (Im)possible I’ – Pulmonary vascular disease.
Publikováno v:
13.01 - Pulmonary hypertension.
Autor:
H Stubbs, A Maclellan, M Mcgettrick, S Lua, F Thompson, B Jani, M Brewis, C Church, M Johnson
Publikováno v:
01.05 - Clinical respiratory physiology, exercise and functional imaging.
Autor:
G Jayasekera, A. Macdonald, C. Mccomb, V. Orchard, D. Welsh, C. Church, M. Johnson, M. Brewis, C. Berry, A. Radjenovic, A. Peacock
Publikováno v:
International journal of cardiology. 365
Left ventricular (LV) filling pressures are normal in idiopathic pulmonary arterial hypertension (IPAH). However, direct and indirect interactions between the RV and LV can affect LV performance. We explored LV strain and LV intra-ventricular dyssync
Autor:
Matthew Johnson, A. MacLellan, Russell Thomson, M McGettrick, P. McCaughey, K Carson, M Brewis, Colin Church, A Crozier
Publikováno v:
Pulmonary hypertension: advances in diagnosis and treatment.
Introduction and objectives Epoprostenol is a synthetic prostacyclin analogue which has been used in the treatment of pulmonary arterial hypertension (PAH) for a number of years. To date, it has been the only disease targeted therapy to have demonstr
Autor:
J Ford, M Brewis, P McCaughy, A MacKenzie, Colin Church, David A. Welsh, K Wilson, T Crowe, Matthew Johnson, G Jayasekera, V Irvine
Publikováno v:
Improving outcomes for patients with pulmonary hypertension.
Introduction A pro-inflammatory phenotype, with evidence of metabolic dysfunction is increasingly being recognised as a distinct entity in Pulmonary Arterial Hypertension (PAH). Current disease targeted therapy in PAH is limited to pulmonary artery v
Autor:
Russell Thomson, P McCaughy, J Ford, M Brewis, V Irvine, A MacKenzie, G Jayasekera, David A. Welsh, F. Kennedy, Matthew Johnson, Colin Church, T Crowe, K Carson
Publikováno v:
Improving outcomes for patients with pulmonary hypertension.
Introduction Despite contemporary drug therapy, many patients with pulmonary arterial hypertension (PAH) have a high symptom burden and prognosis remains poor. Single centre studies have demonstrated significant improvements in exercise capacity and